TL;DR
A large international trial demonstrates that AI software can plan cervical cancer radiotherapy with high accuracy, reducing treatment time and supporting global elimination efforts. The technology shows promise for broader cancer care, especially in low-resource settings.
Results from a large international trial show that an AI-powered radiotherapy planning tool can produce high-quality treatment plans for cervical cancer in over 95% of cases, supporting its use globally. The trial, led by researchers at University College London and the London School of Hygiene & Tropical Medicine, is a significant step toward expanding access to life-saving cancer treatment, especially in low- and middle-income countries where shortages of specialized staff hinder care.
The ARCHERY trial involved over 1,000 patients across hospitals in India, South Africa, Jordan, and Malaysia, focusing on cervical, prostate, and head and neck cancers. The AI software automatically identifies tumor targets and determines optimal radiation beam configurations, tasks traditionally performed manually by oncologists and physicists, which can take days or weeks.
For cervical cancer, the AI achieved a high-standard plan in 94% of cases, while for prostate cancer, it reached 85%, which is considered suitable for routine clinical use. Results for head and neck cancer are expected later this year. The software reduces planning time from several hours or days to just over an hour, potentially decreasing waiting times and increasing treatment capacity.
Why It Matters
This development is significant because it addresses the critical workforce shortage in radiotherapy, especially in low-income countries where only 10% of those who need radiotherapy currently receive it. By enabling faster, high-quality planning, the AI tool could help meet the World Health Organization’s goal of eliminating cervical cancer as a public health problem. It also offers a scalable solution to improve cancer treatment efficiency globally, potentially saving millions of lives annually.
AI-powered radiotherapy planning software
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
Globally, cervical cancer causes approximately 350,000 deaths annually, with the majority occurring in low- and middle-income countries due to limited access to radiotherapy. Traditionally, treatment planning is labor-intensive, requiring specialized staff and multiple days. Previous small-scale studies of AI in radiotherapy have been limited to high-income settings, with little evidence from resource-limited environments. The ARCHERY trial is among the first large, multi-country evaluations demonstrating AI’s potential in diverse healthcare contexts.
“These results show that for cervical cancer, this AI technology achieves a very high standard, supporting its routine use in hospitals globally. It can help meet the WHO’s cervical cancer elimination initiative.”
— Professor Ajay Aggarwal
“Our trial fills an important gap by rigorously testing AI in diverse, resource-limited settings, demonstrating its potential to save lives worldwide.”
— Professor Mahesh Parmar
“Using AI could speed up treatment planning, improve resource use, and help treat more patients, especially in countries with limited radiotherapy capacity.”
— Professor Matthias Guckenberger
Therahab Professional Cervical Traction Device & Neck Stretcher E0849 with Gel Pack – Home Hot Cold Therapy Cervical Decompression System with Accessory Bag
✅ COMPLETE CERVICAL TRACTION SYSTEM: Professional home traction device with pneumatic hand pump, 6 hot/cold gel therapy pads,…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
While results are promising, it remains unclear how widely the AI technology will be adopted in routine clinical practice globally. Further validation in different healthcare systems and long-term outcome data are still needed. The impact on overall survival and quality of life has yet to be established through ongoing follow-up studies.
Python for Medical Imaging: AI, Deep Learning, and Diagnostic Automation: Build Intelligent Medical Image Models with Python, From Radiology to Pathology … Health Science and Bioinformatics Book 2)
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include expanding clinical trials to include more diverse populations and healthcare settings, integrating the AI tool into standard workflows, and conducting long-term outcome assessments. Regulatory approval processes and training programs will also be critical for widespread implementation.
Khan's Treatment Planning in Radiation Oncology
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does the AI improve radiotherapy planning?
The AI automatically identifies tumor targets and calculates optimal radiation beam configurations, reducing planning time from days to just over an hour, while maintaining high treatment quality.
Can this AI tool be used in low-resource settings?
Yes, the AI’s ability to produce high-quality plans quickly and with less specialized staff makes it particularly suitable for low- and middle-income countries where workforce shortages are a major barrier.
Will this AI replace oncologists and physicists?
The AI is designed to support, not replace, clinicians by automating routine tasks and allowing staff to focus on complex decision-making and patient care.
What are the next steps before widespread adoption?
Further validation, regulatory approval, integration into clinical workflows, and training are needed before the AI can be broadly implemented in hospitals worldwide.
